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Abstract
Introduction: Multimorbidity is a major concern in primary care. Nevertheless, evidence of prevalence and patterns of
multimorbidity, and their determinants, are scarce. The aim of this study is to systematically review studies of the
prevalence, patterns and determinants of multimorbidity in primary care.
Methods: Systematic review of literature published between 1961 and 2013 and indexed in Ovid (CINAHL, PsychINFO,
Medline and Embase) and Web of Knowledge. Studies were selected according to eligibility criteria of addressing
prevalence, determinants, and patterns of multimorbidity and using a pretested proforma in primary care. The quality and
risk of bias were assessed using STROBE criteria. Two researchers assessed the eligibility of studies for inclusion (Kappa
= 0.86).
Results: We identified 39 eligible publications describing studies that included a total of 70,057,611 patients in 12 countries.
The number of health conditions analysed per study ranged from 5 to 335, with multimorbidity prevalence ranging from
12.9% to 95.1%. All studies observed a significant positive association between multimorbidity and age (odds ratio [OR],
1.26 to 227.46), and lower socioeconomic status (OR, 1.20 to 1.91). Positive associations with female gender and mental
disorders were also observed. The most frequent patterns of multimorbidity included osteoarthritis together with
cardiovascular and/or metabolic conditions.
Conclusions: Well-established determinants of multimorbidity include age, lower socioeconomic status and gender. The
most prevalent conditions shape the patterns of multimorbidity. However, the limitations of the current evidence base
means that further and better designed studies are needed to inform policy, research and clinical practice, with the goal of
improving health-related quality of life for patients with multimorbidity. Standardization of the definition and assessment of
multimorbidity is essential in order to better understand this phenomenon, and is a necessary immediate step.
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Introduction
Multimorbidity 2 the presence of more than one health
condition in an individual [1,2] 2 is increasingly being recognised
as the norm rather than the exception in primary care patients [3].
Multimorbidity increases the risk of premature death, hospitaliza-
tions, loss of physical functioning, depression, polypharmacy, and
worsening quality of life, translating into a substantial economic
burden for health systems [4]. Information on the prevalence of
multimorbidity and the most frequent combinations of health
conditions is essential for optimum organisation and delivery of
health care [5,6]. The identification of the key determinants of
multimorbidity is a prerequisite for the development of effective
strategies for the early identification of patients at risk and for the
prevention of future health conditions [7].
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A number of studies have examined the prevalence of
multimorbidity, with methods for estimation ranging from simple
counts of the number of diseases per individual to sophisticated
patient classification systems for the measurement of morbidity
burden and case-mix [1]. Recently published systematic reviews
have tried to summarise these studies, but they are not without
limitations, such as omitting information on the determinants
and/or patterns of multimorbidity [8–10] and an exclusive focus
on longitudinal studies [11]. Not least, they quickly became
outdated. A number of relevant studies have been published in the
last few years, and there is an urgent need to establish what is
currently known about the determinants and prevalence of
multimorbidity and the most frequent patterns observed in
primary care.
Our aim was to systematically review and synthesise the
available evidence on the prevalence, major determinants and
patterns of multimorbidity in primary care in order to inform the
organisation and delivery of primary care.
Methods
We conducted a systematic review of the literature for reports of
studies aimed at estimating the prevalence of multimorbidity and/
or determining the predominant patterns or combinations of
health conditions in primary care patients. We defined multi-
morbidity as ‘‘the simultaneous presence of more than one health
condition in the same individual’’ and multimorbidity patterns as
‘‘the simultaneous presence of multiple specific health conditions
in the same individual’’. We considered two types of multi-
morbidity patterns: the most frequent combinations of specific
diseases (pairs and triplets), and the groups of health conditions
with the highest degree of association using the corresponding
statistical analyses (cluster and factor analysis).
Study selection
We included primary studies reporting the prevalence of
multimorbidity and/or the prevalence of patterns of multi-
morbidity in primary care. Four exclusion criteria were applied:
a) articles not reporting original research (reviews, editorials, non-
research letters); b) studies that recruited patients through in non-
primary care settings (hospitals, nursing homes, etc.); thereby
limiting representativeness for Primary Care; c) studies that
recruited patients based on specific characteristics such as the
presence of any specific condition (e.g., diabetes), or any socio-
demographic characteristic other than age; and d) studies using
patients’ self-reported diagnoses.
Search strategy
A protocol was developed using PRISMA guidelines [12]. It is
available at http://www.phc.ox.ac.uk/research/hsprg/research-
projects/multimorbidity/Protocol.SR.PDPMM.1.web.txt. We used
an established, structured methodology for the analysis of electronic
databases, which combined a pre-defined search strategy with a
valid snowball method. The latter is particularly useful when
terminology has not been applied consistently in the literature [1].
We used Ovid to search PubMed-Medline (1960 to July 10, 2013),
EMBASE (1980 to July 10, 2013), PsycINFO (1948 to July 10, 2013)
and CINAHL. A structured search strategy combining text and
MeSH terms identified relevant articles (Table S1). No language
restrictions were applied.
We searched Web of Knowledge for all citing and cited articles
for each eligible paper (backward and forward search). These
references were included in the pool of references to be screened
and were subjected to the same screening processes as those
retrieved from any other database.
Eligibility assessment and data extraction
Two researchers (CV and QFB) assessed the eligibility of studies
for inclusion. Disagreements were mediated by JMV and resolved
by consensus. A pilot test with a sample of studies showed high
inter-rater reliability (Kappa = 0.86).
Relevant information from the selected articles was extracted by
all the researchers using a standardised proforma. For each article,
two authors independently extracted data on the prevalence of
multimorbidity and of the most frequent patterns, along with
publication year, country, study design, sample size, sampling
method, data source, coding system and/or method for the
identification of health conditions, number of health problems
considered as eligible, age range of participants, proportion of
women, methods for modelling of multimorbidity patterns (where
applicable), and all the variables analysed to establish the
determinants of multimorbidity (Figure 1).
Two authors (CV and QFB) used the STROBE checklist for
observational studies to assess the quality of each study (Table S2)
[13]. We conducted a pilot test of the data extraction process to
ensure high inter-rater agreement (Kappa = 0.96). Any disagree-
ments were mediated by JMV and resolved by consensus.
Data analysis
We report descriptive statistics for the estimates of the
prevalence of multimorbidity and the associated patterns. Hetero-
geneity estimates were too high (I2.90% for all analyses) to
support quantitative pooling to confirm qualitative assessment
based on key study characteristics (Table S2). We studied the
association between prevalence estimates and selected study
characteristics using non-parametric tests (Spearman correlation).
We tabulated the significant multimorbidity patterns according to
age and gender whenever possible. We created forest plots for the
association between multimorbidity prevalence and the determi-
nants that had been evaluated in some of the studies. If the original
study did not report any standard measure of association, we
calculated odds ratios (OR) based on the proportion of patients
with and without multimorbidity. We used STATA version 11
throughout (STATA Corp, College Station, TX), except for odds
ratios for the determinants of multimorbidity, which were
calculated using EPIDAT version 3.1. [14].
Results
The electronic and manual searches yielded 7,668 references, of
which 71 were potentially relevant. These references were
reviewed in full text, leading to the inclusion of 39 articles [15–
53] corresponding to 44 studies (see Figure 1). One article included
results from five different samples [43] and another reported
results from two different samples [50] (Table S2).
Sample size ranged from 328 [19] to 31,313,331 [25]
participants. Of the 44 studies, 33 were conducted in Europe
[15–17,19,21–24,26–30,34–35,37,39–41,43,45–52], of which the
majority were conducted in the Netherlands (12 studies)
[29,41,43,45–48,51], Germany (6 studies) [24,39,40,49,50], and
the United Kingdom (5 studies) [16,17,23,26,37]). Eight studies
were conducted in North America, six in the United States
[25,32,33,42,44,53], and two in Canada [20,31], and three studies
were conducted in Australia [18,36,38].
In the 32 studies using data from health records, registers or
administrative claims [16–17,20–26,29,31–39,41–47,49–53], a
variety of classification systems were used, including different
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versions of the International Classification of Primary Care (ICPC)
[22,24,29–30,34–35,38,41,43,45,46–48,51], the International
Classification of Diseases (ICD) versions 9 and 10
[25,27,28,32,33,39,40,42–44,49,50,52,53] and Read codes (the
clinical coding system used in General Practice in the UK)
[16,17,23,26]. One study used a combination of ICD–9 and
International Classification of Health Problems for Primary Care
(ICHPPC–2) [36]. Only three studies [22,35,38] included all
chronic health conditions and used O’Halloran criteria for chronic
disease (147 codes) [54]. The remaining studies (93.2%) selected a
variable number of conditions, which ranged from 5 [41] to 335
[47].
Study quality
Quality was high in most of the studies (median score 18 out of a
maximum STROBE score of 23 (range: 5–23, Table S2). The two
main weaknesses were: insufficient efforts to address potential
sources of bias and sparse information for each variable of interest
on the number of participants with missing data.
Prevalence of multimorbidity
Thirty-nine studies measured the prevalence of multimorbidity.
Overall estimates ranged from 12.9% in participants aged 18 years
and older [51] to 95.1% [19] in a population aged 65 years and
older. With the exception of five studies [17,31,35,45,51], all
estimates exceeded 20% (Figure 2). The most common design
(56.8%) was cross-sectional [15,16,18–26,29–31,36,39,41,43,46,
47,49,52,53] (Table S2).
The definition of multimorbidity differed between studies. In 25
studies, multimorbidity was defined as the presence of at least 2
chronic diseases in the same person [15,16,18,19,21,22,24,25,27,28,
33,34,35,37,43,44,45,47,48,51,52]; in 5 studies as the presence of at
least 3 chronic diseases [39,40,49,50]; in 12 studies by counting the
total number of medical conditions and defining groups accordingly
Figure 1. Flow chart for study identification.
doi:10.1371/journal.pone.0102149.g001
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[20,23,26,30–32,36,38,41,42,46,53]; and 2 studies did not report
these data [17,29].
No association was observed between the overall prevalence of
multimorbidity and any of the selected study characteristics
(design, sample size, sampling, data source, coding system), except
for a slight (non-significant) positive correlation with the number of
health conditions considered (Spearman rho: 0.28; p= 0.11).
Determinants of multimorbidity
Age was the most frequently studied determinant of multi-
morbidity [16,18,20,22,25,27,30,32,34,37,41,47,51,52]. All the
studies showed a significant positive association between age and
prevalence of multimorbidity (Figure 3). A number of other studies
confirmed this observation, although they reported data that could
not be used in the forest plot [21,26,35,36,39,44,45,46,53].
Fourteen studies assessed the association between prevalence of
multimorbidity and gender [47,20,18,27,30,22,37,51,49,16,21,34,
35,25] (Figure 3). Prevalence was significantly higher in women in
nine studies [16,22,25,27,30,34,37,47,51] and non-significantly
higher in three additional studies [18,21,49]. Two studies showed
a slightly higher prevalence in men, but the difference was non-
significant [20,35]. In one study, these comparisons were age-adjusted
[26].
Five studies examined the association between prevalence of
multimorbidity and socioeconomic status, measured using a
deprivation index [16,37], health insurance coverage [22,47]
and educational level [27,47]. Consistently, all these studies
showed an inverse association between socioeconomic status and
multimorbidity. The OR for comparisons of the lowest and
highest socioeconomic status ranged from 1.20 (95% CI 1.10 to
1.31) [47] to 1.91 (95% CI 1.78 to 2.04) [37]. Except for two
studies [16,22], all socioeconomic comparisons were adjusted for
age and gender.
One study found the presence of mental health disorders to be
significantly associated with the prevalence of multimorbidity
adjusted for age and gender [16]. No studies assessed the impact as
determinants of multimorbidity of any specific conditions or well-
established risk factors (e.g., smoking and high blood pressure) that
are independently associated with the incidence of health
conditions commonly present in patients with multimorbidity.
Patterns of multimorbidity
Only 24 studies of 44 [16,18,19,21,24,25,28,33,34,38–40,43–
45,49–52] provided information on patterns of multimorbidity.
Most of these (11 studies) focused on descriptive information
pertaining to the frequency of all possible combinations of two
conditions [16,18,24,28,38,43,51] and three studies described
combinations of two and three conditions [25,45,52]. Hyperten-
sion and osteoarthritis was the most frequent combination,
followed by different combinations of cardiovascular conditions.
In general, the most frequent pairs were made up of the most
frequent single conditions in each study (Figure 4). Four studies
[44,49,50] analysed combinations of three conditions (data not
shown).
As for the identification of meaningful groups of conditions, two
studies used cluster analysis [19,33], and four used factor analysis
[21,34,39,40] (Table 1). There was no consistent pattern across the
clusters among the first set of studies. Three of the four factor
analysis studies stratified their results by gender [34,39,40] and
only one stratified both by gender and age [34]. As with cluster
analysis, there was variation in the composition of the factors.
However, a rather consistent picture emerged, with a number of
factors being common across studies, including a factor comprising
a variety of cardio-metabolic conditions (on occasion split into two
factors), a factor that included anxiety and depression (on occasion
associated with other psychiatric conditions), and a factor
including pain (on occasion associated with anxiety and depres-
sion).
Discussion
This is the first systematic review to provide a comprehensive
analysis of multimorbidity prevalence, determinants and patterns.
There are five major findings: a) estimates of multimorbidity
prevalence and the identification of specific patterns vary widely
between studies (from less than 15% to more than 95%); b) there is
huge variation in sample selection criteria and in the methods for
estimating multimorbidity (eligible conditions, coding systems),
their patterns (including also the different types of analysis:
probabilistic pairs and triplets, cluster analysis, factor analysis); c)
all too frequently there is lack of adherence to some fundamental
principles of epidemiological studies, such as reporting by age and
gender; d) multimorbidity has been consistently associated with
age (the majority of individuals older than 65 years have
Figure 2. Prevalence of multimorbidity by age group: overall (a) and by sex (b).
doi:10.1371/journal.pone.0102149.g002
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multimorbidity), female gender, lower socioeconomic status, as
well as the presence of mental health problems; and e) the most
frequent combinations were those that included osteoarthritis and
a cardio-metabolic cluster of conditions such as high blood
pressure, diabetes, obesity and ischaemic heart disease.
Although estimates for the prevalence of a condition may vary
with different recruitment and sampling methods, classification
systems, and local peculiarities in coding, among other factors, we
were not able to identify any statistically significant association
with such characteristics of study design. Another aspect to
consider is the sources of study data. Data from health records,
registers and administrative claims may detect less complex
problems and under report diseases. Health conditions more
frequently registered in health records could be conditioned by
their severity (cardiac disease and malignant tumour) or by the fact
that some chronic conditions are of particular interest (such as
diabetes mellitus and hypertension in many quality incentive
schemes). Other conditions (such as dementia, some mental health
conditions), may be under-diagnosed and underreported [52]. The
lack of valid and reliable methodological standards for the
identification of multimorbidity may have limited the strength of
statistical analysis, affecting both the estimates of overall preva-
lence and the identification of patterns of multimorbidity.
Differences in the number of eligible conditions ranging from 5
to 335 would clearly have a substantial impact on the observed
characteristics of patients with multimorbidity.Until appropriate
standards are developed and adopted by the research community,
this problem may well continue to constitute one of the most
significant barriers to the advancement of research in this area.
The association between multimorbidity and age has been
established in almost every study on the issue and is consistent with
the notion that the additional life-years constitute an additional
opportunity for acquiring other chronic conditions. It seems a
consistent observation that, almost regardless of the methods used,
multimorbidity is the norm in those aged 65 or older. The
increased frequency with which multimorbidity occurs among
Figure 3. Forest plots for determinants of multimorbidity: odds ratios (ORs) and 95% CIs for age, gender, socioeconomic status
(SES) and existing mental disorder.
doi:10.1371/journal.pone.0102149.g003
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Figure 4. Most frequent pairs of health conditions.
doi:10.1371/journal.pone.0102149.g004
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women demands an explanation. Although it might be in part
attributed to the lack of simultaneous adjustment or stratification
for age and gender in the majority of studies, those that did make
both adjustments also observed an increased prevalence among
women (with OR ranging from 1?12 to 1?50). It is not possible to
disentangle from the current data an explanation of whether this is
due to residual confounding, higher consultation rates in women
leading to higher rates of diagnosis, differential numbers of gender-
specific conditions in each study or indeed differences in the
burden of health conditions. If the latter were truly the case, it
would provide an explanation for the well-established fact that
women tend to rate their health and health-related outcomes as
worse than men [55].
The methods used to provide information on multimorbidity
patterns were inconsistent across the studies that focussed on this
research question. The information provided by the authors does
not allow comparison of the methods used to establish which
approach is the best.
Table 1. Patterns of multimorbidity.
Statistical method First Author (year) Multimorbidity patterns
Cluster analysis Newcomer SR (2011) 1. Chronic pain & mental health conditions (6.6%)
2. Diabetes & obesity & mental health conditions (12.0%)
3. Kidney disease & diabetes & obesity (14.0%).
Formiga F (2012) 1. Auditory impairment*
2. COPD and malignancy*
3. Atrial fibrillation, heart failure, visual impairment, CKD, stroke, high blood pressure and diabetes mellitus*
Factor analysis Prados-Torres A, 2012 Male:
15–45 years:1. Cardio-metabolic (0.9%)
2. Psychiatric-substance abuse (1.5%).
45–64 years:1. Cardio-metabolic (9.2%)
2. Mechanical-obesity-thyroidal (4.9%).




15–45 years:1. Cardio-metabolic (0.4%)
2. Mechanical-obesity-thyroidal (2.7%).
45–64 years:1. Cardio-metabolic (4.1%)
2. Mechanical-obesity-thyroidal (11.7%)
3. Depressive (0.1%).
$65 years:1. Cardio-metabolic (33.3%)
2. Mechanical-obesity-thyroidal (3.5%).
3. Psychogeriatric (17.3%).
Scha¨fer I (2010) Male:
1. Cardiovascular & metabolic disorders (39.0%)
2. Anxiety/depression/somatoform disorders & pain (22.0%)
3. Neuropsychiatric disorders (0.8%)
Female:
1. Cardiovascular & metabolic disorders (30.0%)
2. Anxiety/depression/somatoform disorders & pain (34.0%)
3. Neuropsychiatric disorders (6.0%),
Scha¨fer I (2012) Male:
1. Cardiovascular/metabolic disorders (79.8%).
2. Anxiety, depression, somatoform disorders and pain (46.0%)
Female:
1. Anxiety, depression, somatoform disorders & pain (66.4%)
2. Cardiovascular/metabolic disorders (55.2%)
Garcia L (2012) 1. Hypertension & disorders of lipid metabolism & type2 diabetes & cardiac arrhythmia*
2. Cerebrovascular disease & ischemic heart disease & chronic renal failure & congestive heart failure*
3. Anxiety and depression & thyroid disease & asthma & schizophrenia and affective psychoses*
*No prevalence data reported for this study.
doi:10.1371/journal.pone.0102149.t001
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Strengths and weaknesses of this review
This review has a number of strengths compared to previous
reviews that provide data on the prevalence of multimorbidity in
primary care. We identified a much larger number of studies (39
articles, compared to 21 articles in the most extensive review by
other authors [9]). The review by Marengoni et al was limited to the
population aged 65 years and older, and included patients admitted
to hospitals and nursing homes; for these reasons, our results cannot
be compared [2]. Likewise, the number of cohort studies identified
in our review is far greater than those analysed by other researchers
[11]. None of these previous reviews considered the most frequent
multimorbidity patterns and the associated determinants.
However, our study also has limitations. Although identification
and selection bias are a common threat to validity in all systematic
reviews, they are more likely in reviews of non-randomised studies,
because study registration is not standard practice. Particular
efforts have been devoted to reduce identification bias, as
evidenced by our search strategy including several databases,
enhanced with forward and backward citation mining. Estimates
of prevalence, determinants and patterns in our study are limited
by the methods used in the primary studies. All studies were
conducted in high-income Organisation for Economic Co-
operation and Development (OECD) countries. In middle- and
low-income countries, however, communicable health conditions
play a much larger role in the disease burden and would be
expected to significantly affect prevalence, determinants and
patterns of multimorbidity. We were not able to combine studies
to obtain an overall estimate, due to substantial statistical and
methodological heterogeneity. More generally, the design of the
original studies obviously imposes limits on our ability to establish
inferences, as it is particularly the case for the issue of the
determinants of multimorbidity. However, the consistency of our
observations on the association between multimorbidity and its
determinants supports our confidence in our observations.
Implications for clinical practice, health policy, and future
research
The high prevalence of multiple conditions makes an increased
focus on the routine delivery of specific multimorbidity interven-
tions necessary. Elderly women of lower socio-economic status
seem to be at the highest risk for multimorbidity, particularly in
the presence of mental disorders. Although the evidence base for
the management of multimorbidity appears to be thin and much
more research is still needed [4], current best practice should focus
on the prevention of common risk factors and an orientation of
treatment towards the improvement of functional limitations.
Furthermore, in light of this review, expert consensus seems to be
essential to establish an operational definition of multimorbidity
that facilitates comparison between different world regions.
Patients with multimorbidity need coordinated and continuing
care. These are core functions of Primary Care. Payment systems
will need to appropriately take these roles into account and reward
them accordingly (e.g., it is more complex to manage a patient
with a number of different conditions than the same number of
patients each with a single condition).
Research is particularly needed on the clustering of conditions
in patients with multimorbidity. From an etiological perspective, it
is important to understand what makes conditions tend to co-
occur, with the aim of being able to prevent their development in
the first place. On the other hand, from a clinical perspective with
a focus on ongoing management of patients with multimorbidity,
the identification of particularly frequent associations is important
relevant to identifying therapeutic approaches that take comor-
bidity into account and allow the tailoring of care for significant
strata of people with a given condition or combination of conditions.
Finally, from a policy perspective, targeting both modifiable
determinants of multimorbidity and common risk factors for
conditions pertaining to the same cluster will be an efficient
approach to preventing multimorbidity and its associated risks.
Progress will continue to be impaired by poor design of studies
of multimorbidity. Until formal consensus on the best methods for
the study of multimorbidity and multimorbidity patterns is
developed, these studies should consider the following minimal
standards: a) unrestricted eligibility of conditions rather than
selected subsamples of conditions, in order to ensure replicability
and comparability across studies, or less ideally, agreement on a
defined list of key conditions; b) diagnoses confirmed by health
professionals, using established coding systems [56]; and c) reporting
of results stratified by age and gender. Research comparing different
methods for the identification of beyond chance association and
clustering of conditions is urgently needed. Further research is also
needed on the association between multimorbidity and modifiable
risk factors such as smoking and diet, and explanatory research into
gender differences. Finally, we lack fundamental information about
multimorbidity in lower and middle-income countries where patterns
of disease will more frequently include communicable diseases, such
as malaria, tuberculosis and HIV infection. A coordinated effort
similar to that which resulted in the Global Burden of Disease study
would be needed [57].
Conclusions
Although multimorbidity estimates and patterns are heavily
dependent on the measurement methods, there is evidence that a
substantial proportion of the primary care population is affected.
Well-established determinants of multimorbidity include age,
gender, and lower socioeconomic status, and it has also been
associated with the presence of mental disorders. However, the
substantial limitations identified across the studies included in this
review means that available evidence is not enough, and much
more research is needed. In particular, the standardization of the
definition and the assessment of multimorbidity is essential in
order to better understand this phenomenon.
Clinical practice and health policy needs to orient the delivery
of care to ensure that the resources match the needs of this group
of complex patients.
Supporting Information
Table S1 Search Strategies for the Electronic Databases.
(DOCX)
Table S2 Studies included in the systematic review.
(DOCX)
Checklist S1 PRISMA Checklist.
(DOC)
Acknowledgments
The authors thank Carmen Iba´n˜ez for administrative support.
Ethical approval: Not required.
Author Contributions
Conceived and designed the experiments: JMV CV QFB. Performed the
experiments: JMV CV QFB GFM CS JB MF LG CM. Analyzed the data:
QFB CV GFM JMV. Contributed reagents/materials/analysis tools: JMV
CV QFB GFM CS JB MF LG CM. Wrote the paper: QFB CV GFM
JVM. Critically revised and approved final version of the manuscript: JMV
CV QFB GFM CS JB MF LG CM.
Prevalence, Determinants, Multimorbidity in Primary Care
PLOS ONE | www.plosone.org 8 July 2014 | Volume 9 | Issue 7 | e102149
References
1. Valderas JM, Starfield B, Sibbald B, Sibbald B, Salisbury C, et al. (2009)
Defining comorbidity: implications for understanding health and health services.
Ann Fam Med 7: 357–63.
2. Marengoni A, Angleman S, Melis R, Mangialasche F, Karp A, et al. (2011)
Aging with multimorbidity: a systematic review of the literature. Ageing Res Rev
10: 430–9.
3. Salisbury C (2012) Multimorbidity: redesigning health care for people who use
it. Lancet 380: 7–9.
4. Smith SM, Soubhi H, Fortin M, Hudon C, O’Dowd T (2012) Managing
patients with multimorbidity: systematic review of interventions in primary care
and community settings. BMJ 345: e5205.
5. Stange KC (2012) Challenges of managing multimorbidity. Ann Fam Med 10:
2–3.
6. Guthrie B, Payne K, Alderson P, McMurdo ME, Mercer SW (2012) Adapting
clinical guidelines to take account of multimorbidity. BMJ 345:e6341.
7. Harkness E, Macdonald W, Valderas J, Coventry P, Gask L, et al. (2010)
Identifying psychosocial interventions that improve both physical and mental
health in patients with diabetes: a systematic review and meta-analysis. Diabetes
Care 33: 926–30.
8. Vogeli C, Shields AE, Lee TA, Gibson TB, Marder WD, et al. (2007) Multiple
Chronic Conditions: Prevalence, Health Consequences and Implications for
Quality, Care Management, and Costs. J Gen Intern Med 22 (Suppl 3):391–95.
9. Fortin M, Stewart M, Poitras ME, Almirall J, Maddocks H (2012) A systematic
review of prevalence studies on multimorbidity: toward a more uniform
methodology. Ann Fam Med 10: 142–51.
10. Huntley AL, Johnson R, Purdy S, Valderas JM, Salisbury C (2012) Measures of
multimorbidity and morbidity burden for use in primary care and community
settings: a systematic review and guide. Ann Fam Med 10: 134–41.
11. France EF, Wyke S, Gunn JM, Mair FS, McLean G, et al. (2012)
Multimorbidity in primary care: a systematic review of prospective cohort
studies. Br J Gen Pract 2012; 62:e297–307.
12. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group (2009) Preferred
reporting items for systematic reviews and meta-analyses: the PRISMA
statement. PLoS Med 6: e1000097.
13. Vandenbroucke JP, von Elm E, Altman DG, Gøtzsche PC, Mulrow CD, et al.
(2007) Strengthening the Reporting of Observational Studies in Epidemiology
(STROBE): explanation and elaboration. PLoS Med 4: e297.
14. Santiago Pe´rez MI, Hervada Vidal X, Naveira Barbeito G, Silva LC, Farin˜as H,
et al. (2010) The Epidat program. Rev Panam Salud Publica 27: 80–2.
15. Abete P, Testa G, Della Morte D, Mazzella F, Galizia G, et al. (2004)
Comorbility in the elderly: Epidemiology and clinical features. G Gerontol 52:
267–72.
16. Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, et al. (2012) Epidemiology
of multimorbidity and implications for health care, research, and medical
education: a cross-sectional study. Lancet 380: 37–43.
17. Brilleman SL, Purdy S, Salisbury C, Windmeijer F, Gravelle H, et al. (2013)
Implications of comorbidity for primary care costs in the UK: a retrospective
observational study. Br J Gen Pract 63(609):e274–82.
18. Britt HC, Harrison CM, Miller GC, Knox SA (2008) Prevalence and patterns of
multimorbidity in Australia. Med J Aust 189: 72–7.
19. Formiga F, Ferrer A, Sanz H, Marengoni A, Alburquerque J, et al. (2013)
Patterns of comorbidity and multimorbidity in the oldest old: The Octabaix
study. Eur J Intern Med 24: 40–4.
20. Fortin M, Bravo G, Hudon C, Vanasse A, Lapointe L (2005) Prevalence of
multimorbidity among adults seen in family practice. Ann Fam Med 3: 223–8.
21. Garcı´a-Olmos L, Salvador CH, Alberquilla A´, Lora D, Carmona M, et al.
(2012) Comorbidity patterns in patients with chronic diseases in general practice.
PLoS One 7: e32141.
22. Glynn LG, Valderas JM, Healy P, Burke E, Newell J, et al. (2011) The
prevalence of multimorbidity in primary care and its effect on health care
utilization and cost. Fam Pract 28: 516–23.
23. UT, Croft PR; North Staffordshire GP Consortium Group (2007) Clinical
multimorbidity and physical function in older adults: a record and health status
linkage study in general practice. Fam Pract 24: 412–9.
24. Laux G, Kuehlein T, Rosemann T, Szecsenyi J (2008) Co- and multimorbidity
paterns in primary care based on episodes of care: results from the German
CONTENT project. BMC Health Serv Res 2008; 8: 14.
25. Lochner KA, Cox CS (2013) Prevalence of multiple chronic conditions among
Medicare beneficiaries, United States, 2010. Prev Chronic Dis 10:e61.
26. Macleod U, Mitchell E, Black M, Spence G (2004) Comorbidity and
socioeconomic deprivation: an observational study of the prevalence of
comorbidity in general practice. Eur J Gen Pract 10: 24–6.
27. Marengoni A, Winblad B, Karp A, Fratiglioni L (2008) Prevalence of chronic
diseases and multimorbidity among the elderly population in Sweden.
Am J Public Health 98: 1198–200.
28. Marengoni A, Rizzuto D, Wang HX, Winblad B, Fratiglioni L (2009) Patterns of
Chronic Multimorbidity in the Elderly Population. J Am Geriatr Soc 57: 225–
30.
29. Metsemakers JF, Ho¨ppener P, Knottnerus JA, Kocken RJ, Limonard CB (1992)
Computerized health information in The Netherlands: a registration network of
family practices. Br J Gen Pract 42: 102–6.
30. Minas M, Koukosias N, Zintzaras E, Kostikas K, Gourgoulianis KI (2010)
Prevalence of chronic diseases and morbidity in primary health care in central
Greece: an epidemiological study. BMC Health Serv Res 10: 252.
31. Muggah E, Graves E, Bennett C, Manuel DG (2012). The impact of multiple
chronic diseases on ambulatory care use; a population based study in Ontario,
Canada. BMC Health Serv Res 12: 452.
32. Naessens JM, Stroebel RJ, Finnie DM, Shah ND, Wagie AE, et al. (2011) Effect
of multiple chronic conditions among working-age adults. Am J Manag Care 17:
118–22.
33. Newcomer SR, Steiner JF, Bayliss EA (2011) Identifying subgroups of complex
patients with cluster analysis. Am J Manag Care 17: e324–32.
34. Prados-Torres A, Poblador-Plou B, Caldero´n-Larran˜aga A, Gimeno-Feliu LA,
Gonza´lez-Rubio F, et al. (2012) Multimorbidity patterns in primary care:
interactions among chronic diseases using factor analysis. PLoS One 7: e32190.
35. Rizza A, Kaplan V, Senn O, Rosemann T, Bhend H, et al. (2012) Age- and
gender-related prevalence of multimorbidity in primary care: the swiss fire
project. BMC Fam Pract 13: 113.
36. Rose AT (1984) Chronic illness in a general practice. Fam Pract 1: 162–7.
37. Salisbury C, Johnson L, Purdy S, Valderas JM, Montgomery AA (2011)
Epidemiology and impact of multimorbidity in primary care: a retrospective
cohort study. Br J Gen Pract 61: e12–21.25.
38. Saltman DC, Sayer GP, Whicker SD (2005) Co-morbidity in general practice.
Postgrad Med J 81: 474–80.
39. Scha¨fer I, von Leitner EC, Scho¨n G, Koller D, Hansen H, et al. (2010)
Multimorbidity patterns in the elderly: a new approach of disease clustering
identifies complex interrelations between chronic conditions. PLoS One
5:e15941.
40. I, Hansen H, Scho¨n G, Ho¨fels S, Altiner A, et al. (2012) The influence of age,
gender and socio-economic status on multimorbidity patterns in primary care.
First results from the multicare cohort study. BMC Health Serv Res 12: 89.
41. Schellevis FG, van der Velden J, van de Lisdonk E, van Eijk JT, van Weel C
(1993) Comorbidity of chronic diseases in general practice. J Clin Epidemiol 46:
469–73.
42. Schneider KM, O’Donnell BE, Dean D (2009) Prevalence of multiple chronic
conditions in the United States Medicare population. Health Qual Life
Outcomes 7: 82.
43. Schram MT, Frijters D, van de Lisdonk EH, Ploemacher J, de Craen AJ, et al.
(2008) Setting and registry characteristics affect the prevalence and nature of
multimorbidity in the elderly. J Clin Epidemiol 61: 1104–12.
44. Steinman MA, Lee SJ, John Boscardin W, Miao Y, Fung KZ, et al. (2012)
Patterns of multimorbidity in elderly veterans. J Am Geriatr Soc 60: 1872–80.
45. Tacken MA, Opstelten W, Vossen I, Smeele IJ, Calsbeek H, et al. (2011)
Increased multimorbidity in patients in general practice in the period 2003–
2009. Ned Tijdschr Geneeskd 155:A3109.
46. Uijen AA, van de Lisdonk EH (2008) Multimorbidity in primary care:
prevalence and trend over the last 20 years. Eur J Gen Pract 14 Suppl 1: 28–32.
47. van den Akker M, Buntinx F, Metsemakers JF, Roos S, Knottnerus JA (1998)
Multimorbidity in general practice: prevalence, incidence, and determinants of
co-occurring chronic and recurrent diseases. J Clin Epidemiol 51(5):367–75.
48. van den Akker M, Vos R, Knottnerus JA (2006) In an exploratory prospective
study on multimorbidity general and disease-related susceptibility could be
distinguished. J Clin Epidemiol 59(9):934–9.
49. van den Bussche H, Scho¨n G, Kolonko T, Hansen H, Wegscheider K, et al.
(2011) Patterns of ambulatory medical care utilization in elderly patients with
special reference to chronic diseases and multimorbidity-results from a claims
data based observational study in Germany. BMC Geriatr 11: 54.
50. van den Bussche H, Scha¨fer I, Wiese B, Dahlhaus A, Fuchs A, et al. (2013) A
comparative study demonstrated that prevalence figures on multimorbidity
require cautious interpretation when drawn from a single database. J Clin
Epidemiol 66(2):209–17.
51. van Oostrom SH, Picavet HS, van Gelder BM, Lemmens LC, Hoeymans N, et
al. (2012) Multimorbidity and comorbidity in the Dutch population-data from
general practices. BMC Public Health 12: 715.
52. Viola´n C, Foguet-Boreu Q, Hermosilla-Pe´rez E, Valderas JM, Bolı´bar B, et al.
(2013) Comparison of the information provided by electronic health records data
and a population health survey to estimate prevalence of selected health
conditions and multimorbidity. BMC Public Health 13: 251.
53. Wolff JL, Starfield B, Anderson G (2002) Prevalence, expenditures, and
complications of multiple chronic conditions in the elderly. Arch Intern Med
162: 2269–7.
54. O’Halloran J, Miller GC, Britt H (2004) Defining chronic conditions for primary
care with ICPC-2. Fam Pract 21: 381–6.
55. Ware JE, Kosinski M, Bjorner JB, Turner-Bowker DM, Gandek B, et al. (2007)
User’s manual for the SF-36v2 health survey. Lincoln: QualityMetric
Incorporated.
56. Le Reste JY, Nabbe P, Manceau B, Lygidakis C, Doerr C, et al. (2013) The
European general practice research network presents a comprehensive definition
of multimorbidity in family medicine and long term care, following a systematic
review of relevant literature. J Am Med Dir Assoc 14: 319–25.
57. Murray CJ, Frenk J, Piot P, Mundel T (2013) GBD 2.0: a continuously updated
global resource. Lancet 382(9886):9–11.
Prevalence, Determinants, Multimorbidity in Primary Care
PLOS ONE | www.plosone.org 9 July 2014 | Volume 9 | Issue 7 | e102149
